Cargando…
Mouse medulloblastoma driven by CRISPR activation of cellular Myc
MYC-driven Group 3 (G3) medulloblastoma (MB) is the most aggressive of four molecular subgroups classified by transcriptome, genomic landscape and clinical outcomes. Mouse models that recapitulate human G3 MB all rely on retroviral vector-induced Myc expression driven by viral regulatory elements (R...
Autores principales: | Vo, BaoHan T., Kwon, Jin Ah, Li, Chunliang, Finkelstein, David, Xu, Beisi, Orr, Brent A., Sherr, Charles J., Roussel, Martine F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992137/ https://www.ncbi.nlm.nih.gov/pubmed/29880921 http://dx.doi.org/10.1038/s41598-018-24956-1 |
Ejemplares similares
-
Targeting protein folding in N‐Myc‐driven medulloblastoma
por: Valinciute, Gintvile, et al.
Publicado: (2023) -
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells
por: Kawauchi, D, et al.
Publicado: (2017) -
OMIC-03. TRANSLATIONAL CONTROL IN MYC AND MYCN MEDULLOBLASTOMA
por: Schmidt, Christin, et al.
Publicado: (2021) -
Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition
por: Graziani, Vittoria, et al.
Publicado: (2023) -
Primary cilia control translation and the cell cycle in medulloblastoma
por: Youn, Yong Ha, et al.
Publicado: (2022)